Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-16-104951

Chief Executive Officer acquired 3,472 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Quart Barry D · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-03-02 Exercise or conversion : show line 1 in the form +3,472 $7.20 $24,998 60,842 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-03-02 Exercise or conversion : show line 2 in the form Employee Stock Option (Right to Buy) −3,472 $7.20 2023-05-01 3,472 934,907 D
Loading xslF345X03/doc4.xml…